Riluzole for treatment-resistant bipolarity depression
About this title
Riluzole in the Treatment of Bipolar Depression
Read the official source — NCT00544544Researchers studied Riluzole to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Understand this study
What did researchers investigate?
Researchers studied Riluzole to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- BelmontSee all locations and recruitment
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00544544
- Official title
Show the full official title
Riluzole in the Treatment of Bipolar Depression: A Study of the Association Between Clinical Response and Change in Brain Glutamate Levels as Measured by Proton Magnetic Resonance Spectroscopy
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Belmont
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied Riluzole to find out how it affected depression symptoms in people with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Riluzole.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
